-
Immune Response Shown in Alzheimer’s Vaccine
Results from a clinical trial show an experimental vaccine produces antibodies for breaking up harmful brain deposits in people with early Alzheimer’s disease.
-
AbbVie Licenses Engineered Crispr Cell Process
Drug maker AbbVie is acquiring a technology using the gene-editing process Crispr to produce new off-the-shelf engineered T-cells as disease therapies.
-
FDA Clears Covid-19 Dual-Antibody Therapy
The Food and Drug Administration granted an emergency authorization for a combination of two synthetic antibodies to treat non-hospitalized Covid-19 infections.
-
Smartwatch Shown to Offer Early Covid-19 Warning
A study shows heart rate data captured by an Apple watch can provide an early warning of impending Covid-19 infections, even before a positive test.
-
$100M Challenge Seeks Carbon Removal Technologies
An XPrize challenge competition, sponsored by Elon Musk, is seeking new technologies that remove large quantities of carbon dioxide from the atmosphere.
-
New Venture Fund Backs Underserved, Academic Start-Ups
A new $300 million venture capital fund is underway that aims to support technology start-ups often left behind by larger mainstream investors.
-
Infographic – U.S. Covid-19 Shots on the Rise
Despite daily fluctuations, the trend shows a growing number Americans injected with one of the two vaccines authorized so far.
-
Biotech, UK Govt to Design Covid-19 Variant Vaccines
A biotechnology company and a U.K. government agency agreed to quickly develop and produce vaccines to protect against emerging Covid-19 viral mutations.
-
Apple Watch Helps Personalize Parkinson’s Care
A new study shows an Apple watch can capture data on tremors experienced by people with Parkinson’s disease to help provide more precise care.
-
Engineered Cell Therapy Company Issues $588M IPO
A company developing regenerative therapies with engineered stem cells for cancer and other diseases is raising $587.5 million in its initial public offering or IPO.